CD4 and glioblastoma: Overall, the ratio of IL-12: IL-10, which determines CD4 + T cell polarisation, significantly favored Th1 response in healthy controls compared to GBM patients (p = 0.032).32 This represents an impairment in GBM patients to orchestrate appropriate anti-tumor immune responses.